Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...
NEW YORK, NY, UNITED STATES, May 15, 2025 / EINPresswire.com / -- Ace Therapeutics, a leading IBD research service company, revealed its novel IBD animal models, created to bridge the complex ...
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract affecting 1 in 100 Americans (around 2.4 million people) that can lead to disabling bowel symptoms and ...
SAN DIEGO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (ONVO), a clinical stage biotechnology company that is focused on developing FXR314 in inflammatory bowel disease (IBD), including ...
Red cabbage is grown and eaten all over the world, and it can provide many beneficial nutrients including vitamins, antioxidants, polyphenols, and secondary plant metabolites called glucosinolates, ...
Inflammatory bowel disease (IBD) is a complex condition that requires a lifetime of care and increases a person's cancer risk. But its origins are still a mystery. Now, a team of researchers have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback